Secondary efficacy endpoints
The adjusted mean changes from baseline in the HAM-DA statistical significance was observed in the mean changes of CGI-S score, HAMA total score, and SDS total score from baseline for both dosages of ansofaxine CGI-I and CGI-S scores differed significantly for ansofaxine in both dose groups 